Enlivex Therapeutics Ltd (ENLV)
0.8800 x 2 1.0600 x 5
Pre-market by (Cboe BZX)
1.0456 +0.0156 (+1.51%) 04/29/25 [NASDAQ]
0.8800 x 2 1.0600 x 5
Pre-market 1.0456 unch (unch) 15:55 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ENLV | CASI | VYNE | ||
| Company | Enlivex Therapeutics Ltd | Casi Pharmaceuticals Inc | Vyne Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.0300 | 2.08 | 1.4200 | ||
| High | 1.0500 | 2.08 | 1.4950 | ||
| Low | 1.0000 | 1.92 | 1.3700 | ||
| Last | 1.0456 | 2.00 | 1.4100 | ||
| Change | +0.0156 | -0.09 | -0.0300 | ||
| % Change | +1.51% | -4.09% | -2.08% | ||
| Volume | 42,200 | 5,700 | 162,000 | ||
| 20-Day Average Volume | 61,790 | 12,985 | 202,645 | ||
| Previous Close | 1.0300 | 2.08 | 1.4400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9270 | 2.02 | 1.6490 | ||
| 20-Day Raw Stochastic | 97.90% | 21.30% | 18.23% | ||
| 20-Day Relative Strength | 54.92% | 44.11% | 36.96% | ||
| Weighted Alpha | -37.41 | -53.07 | -53.36 | ||
| Today's Opinion | 64% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 80% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.48% since 04/22/25 | +0.76% since 04/22/25 | -24.19% since 04/22/25 | ||
| Low | 0.8730 on 04/24/25 | 1.92 on 04/29/25 | 1.2800 on 04/25/25 | ||
| High | 1.0500 on 04/29/25 | 2.08 on 04/29/25 | 1.9933 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +2.51% since 03/28/25 | -7.10% since 03/28/25 | -17.06% since 03/28/25 | ||
| Low | 0.8400 on 04/16/25 | 1.88 on 04/10/25 | 1.2800 on 04/25/25 | ||
| High | 1.0500 on 04/29/25 | 2.42 on 04/02/25 | 1.9933 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | -5.72% since 01/29/25 | -15.64% since 01/29/25 | -43.60% since 01/29/25 | ||
| Low | 0.8400 on 04/16/25 | 1.88 on 04/10/25 | 1.2800 on 04/25/25 | ||
| High | 1.2900 on 03/14/25 | 2.68 on 02/06/25 | 2.9400 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | -26.88% since 10/29/24 | -67.48% since 10/29/24 | -47.58% since 10/29/24 | ||
| Low | 0.8101 on 11/21/24 | 1.88 on 04/10/25 | 1.2800 on 04/25/25 | ||
| High | 1.4700 on 10/30/24 | 6.30 on 11/05/24 | 4.3000 on 01/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 22,382 | 24,536 | 21,446 | ||
| Shares Outstanding, K | 21,406 | 12,299 | 15,210 | ||
| Annual Sales | 0 | 28,540,000 | 500,000 | ||
| Annual Net Income | -15,010,000 | -39,260,000 | -39,830,000 | ||
| Last Quarter Sales | 0 | 13,360,000 | 80,000 | ||
| Last Quarter Net Income | -5,180,000 | -14,370,000 | -12,020,000 | ||
| 60-Month Beta | 0.85 | 0.66 | 1.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 03/31/25 | -0.79 on 03/31/25 | -0.28 on 03/06/25 | ||
| Latest Earnings Date | 06/13/25 | 05/13/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||